BrainStorm Cell Therapeutics
BCLI
#9868
Rank
$6.43 M
Marketcap
$1.21
Share price
7.08%
Change (1 day)
572.22%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -$12.5 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -$24.28 Million USD, an increase over its 2021 earnings that were of -$24.46 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$12.5 Million
2022 -$24.28 Million-0.74%
2021 -$24.46 Million-23.12%
2020 -$31.82 Million36.8%
2019 -$23.26 Million66.71%
2018 -$13.95 Million181.66%
2017 -$4.96 Million-0.6%
2016 -$4.99 Million-41.31%
2015 -$8.49 Million-8.22%
2014 -$9.25 Million89.74%
2013 -$4.88 Million42.27%
2012 -$3.43 Million-12.45%
2011 -$3.92 Million63.04%
2010 -$2.4 Million35.52%
2009 -$1.78 Million-48.99%
2008 -$3.48 Million-44.39%
2007 -$6.25 Million
2005 -$3.24 Million-91.44%
2004 -$37.78 Million94007.62%
2003 -$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$1.53 B-12,406.95%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.55 Billion 4,263.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.8 Billion 6,226.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.31 B-10,613.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.11 Billion 758.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.26 Billion 1,944.40%๐Ÿ‡บ๐Ÿ‡ธ USA